NCT07212491 2026-04-17
Minimally Invasive Molecular Approaches for the Detection of Barrett's Esophagus- High Grade Dysplasia and Esophageal Adenocarcinoma
Mayo Clinic
Enrolling by invitation
Clinical Trials
12 trialsNCT07328516 2026-04-17
Natural History Study of Early Life Exposures in Agriculture (ELEA)
National Institutes of Health Clinical Center (CC)
Enrolling by invitation
NCT07537205 2026-04-17
The Effects of a Nurse-led TGA-based Pre-rehabilitation Planning on Perioperative Outcomes in Patients With Liver Cancer: Study and Protocol
Fudan University
Phase NA Enrolling by invitation
NCT07533825 2026-04-16
CGCA202501
Tianjin Medical University Cancer Institute and Hospital
Phase NA Enrolling by invitation
NCT00068003 2026-04-14
Harvesting Cells for Experimental Cancer Treatments
National Institutes of Health Clinical Center (CC)
Enrolling by invitation
NCT06133439 2026-04-14
RISCC
Indiana University
Phase NA Enrolling by invitation
NCT07517419 2026-04-08
PIPAC in Gastric Peritoneal Metastasis
Chinese University of Hong Kong
Phase 2 Enrolling by invitation
NCT06509022 2026-04-06
Longitudinal Study on the Evolution Trend and Influencing Factors of Postoperative Reflux of Esophageal Cancer Based on PEPTEST Technique
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Enrolling by invitation
NCT06506955 2026-04-03
Futibatinib in Patients Previously Enrolled in an Antecedent Futibatinib as Monotherapy or Combination Therapy.
Taiho Oncology, Inc.
Phase 2/3 Enrolling by invitation
NCT07503847 2026-03-31
Shared Decision-Making for Colorectal Cancer Screening in High-Risk First-Degree Relatives Aged 40-49
National Taiwan University Hospital
Phase NA Enrolling by invitation
NCT07218003 2026-03-23
A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4
Rondo Therapeutics
Phase 1 Enrolling by invitation
NCT07488312 2026-03-23
LUCENT-GC-01
Qilu Hospital of Shandong University
Phase 1 Enrolling by invitation